MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit

Catalog # Availability Size / Price Qty
MAGM209
Enrichment of SCF R/c-kit in Bone Marrow Lineage-negative Cells.
2 Images
Product Details
Procedure
Citations (10)
FAQs
Supplemental Products
Reviews

MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit Summary

Kit Summary

To isolate hematopoietic non-lineage committed cells (lineage-negative) from mouse bone marrow.

Key Benefits

  • Less than 5% residual lineage-positive cells remain after depletion
  • Isolated HSCs are untouched by beads or antibodies
  • Negative selection reduces sources of experimental variation

 

Why Isolate Lineage Negative Hematopoietic Cells by Negative Selection?

Both positive and negative selection methods can be used to generate cell suspensions with high purity. However, cells enriched by positive selection can generate cells that are labeled with antibodies and/or beads

These modifications can introduce experimental variability and can invalidate the use of certain antibodies in downstream applications such as flow cytometry. To efficiently obtain untouched cells of high purity by negative selection, R&D Systems offers the MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit. The MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit uses a magnet and a cocktail of antibodies to remove unwanted, lineage positive cells from a cell suspension. Non-lineage committed mouse hematopoietic cells isolated with the kit are untouched by antibodies or magnetic particles and can be used for any downstream application.

Magnetic depletion of lineage-committed mouse hematopoietic cells:

  • Enriches SCF R/c-kit/CD117+ cells to a purity of 40-70%.
  • Results in less than 5% residual lineage-positive cells remaining after depletion.
  • Targets these lineage-committed cells (lineage positive) for depletion:
    • T cells
    • B cells
    • NK cells
    • Monocytes/macrophages
    • Granulocytes
    • Erythrocytes
  • Does not introduce added sources of experimental variability associated with positive selection.
 

 

Components

The MagCellect Mouse Hematopoietic Cell Lineage Depletion kit contains the following reagents for isolation of uncommitted hematopoietic cells from mouse bone marrow:

  • A cocktail of biotinylated Rat Anti-Mouse Monoclonal Antibodies against CD5, TER-119, CD11b, CD45R/B220, and Ly-6G/Gr-1
  • Wash buffer
  • Streptavidin ferrofluid
  • Blocking reagent

*This kit requires the MagCellect Magnet; sold separately (Catalog # MAG997 or equivalent).

Stability and Storage

Store all reagents at 2 °C to 8 °C. DO NOT FREEZE.

 

Specifications

Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Species
Mouse

Product Datasheets

You must select a language.

x

Scientific Data

Enrichment of SCF R/c-kit in Bone Marrow Lineage-negative Cells. SCF R/c-kit staining of bone marrow lineage-negative cells isolated from BALB/c mice using the MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit (Catalog # MAGM209). Histograms reflect the reactivity of all viable cells with a PE-conjugated Rat Anti-Mouse SCF R/c-kit Monoclonal Antibody (Catalog # FAB1356P; filled histogram) or a PE-conjugated Rat IgG2A Isotype Control (Catalog # IC006P; open histogram) before (A) or (B) after lineage depletion.

Depletion of Lineage-committed Hematopoietic Cells. Lineage marker reactivity on BALB/c bone marrow (BM) cells processed with the MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit (Catalog # MAGM209). The histograms show the reactivity of BM cells labeled with the cocktail of biotinylated antibodies (Rat Anti-Mouse CD5, CD11b, B220/CD45R, Gr-1/Ly-6G, and TER-119) included in the kit both before (green histogram) and after (purple histogram) magnetic depletion. Lineage marker reactivity was detected using Streptavidin-PE.

Assay Procedure

Refer to the product datasheet for complete product details.

Briefly, mouse lineage-negative hematopoietic cells can be isolated using the following procedure:

  • Incubate the single-cell suspension with the MagCellect Antibody Cocktail
  • Add the MagCellect Streptavidin Ferrofluid
  • Place the tube in a magnetic field
  • Collect the desired cells while undesired cells remain attracted to the magnet
 

 

Kit Components

Reagents Supplied in the MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit (Catalog # MAGM209)

  • MagCellect Mouse Cell Lineage Depletion Biotinylated Antibody Cocktail; 1 mL in PBS with BSA
  • MagCellect Streptavidin Ferrofluid; 2 mL in solution containing BSA and preservatives
  • MagCellect Blocking Reagent; 0.5 mL rat IgG in PBS with BSA
  • MagCellect Plus Buffer (10X) – 25 mL of 10X concentrate

This kit contains sufficient reagents to process up to 1 x 109 total cells.

 

 

Other Supplies Required
  • MagCellect Magnet (Catalog # MAG997) or equivalent
  • 12 x 75 mm (5mL) polystyrene round bottom tubes
  • Sterile Pasteur pipettes or transfer pipettes
  • Centrifuge
  • Conical centrifuge tubes
 

 

Procedure Overview

Generate a mononuclear suspension in cold 2% FBS-PBS.

Wash the cells once with Hank’s BSS containing 10% bovine serum.

Centrifuge the cells at 300 x g for 8 minutes.

Enrich for mononuclear cells by using a density gradient or any other method that provides a single cell suspension.

Decant the supernatant.

Resuspend the cells in cold 1X MagCellect Plus Buffer.

Decant the supernatant.

Perform a cell count.

Perform a cell count.

Transfer 1 x 108 cells (5 mL) into a 15 mL centrifuge tube.

Add 50 µL of MagCellect Blocking Reagent.

Incubate at 2 °C to 8 °C for 15 minutes.

Add 100 µL of MagCellect Mouse Cell Lineage Depletion Biotinylated Antibody Cocktail.

Mix the cell-antibody suspension gently.

Incubate at 2 °C to 8 °C for 15 minutes.

Centrifuge the cells at 300 x g for 8 minutes.

Transfer 20 x 10 8 cells (1.0 mL) into a 5-mL polystyrene tube.

Resuspend the cells in 1 mL of cold 1X MagCellect Buffer.

Add 150 µL of MagCellect Streptavidin Ferrofluid to the cell suspension.

Mix gently.

Incubate at 2 °C to 8 °C for 15 minutes.

Add 250 uL of MagCellect Streptavidin Ferrofluid to the cell suspension.

Add 0.85 mL of 1X MagCellect Plus Buffer.

Mix gently.

Add 1.6 mL of cold 1X MagCellect Plus Buffer.

Place the reaction tube in the MagCellect Magnet.

Incubate at room temperature for 6 minutes to remove undesired cells. Magnetically tagged cells will migrate toward the magnet (these are the unwanted cells), leaving the mouse lineage-negative cells in suspension in the supernatant.

Place the reaction tube in the MagCellect Magnet.

Transfer the supernatant containing the mouse lineage-negative cells into a new 5 mL tube.

Repeat the magnetic depletion with the new tube containing the recovered cells. The supernatant obtained at the end of these steps is the final depleted cell fraction containing the desired enriched lineage-negative hematopoietic cells.

Repeat the magnetic depletion with the new tube containing the recovered cells. The supernatant obtained at the end of this step is the final depleted cell fraction containing the desired enriched CD4+ T cells.

The cells are now ready for counting and further downstream applications. The resulting cell population is typically highly enriched for CD117+ cells (40-70%) with less than 5% residual lineage-positive cells.

Add 10 uL of MagCellect Mouse CD25+ T Cell Biotinylated Antibody Cocktail per 1 x 10 7 cells.
 

 

Technical Hints

  • If sterile cells are required following the cell selection, the entire procedure should be carried out in a laminar flow hood to maintain sterile conditions. Use sterile equipment when pipetting reagents that will be reused at a later date.
  • Avoid antibody capping on cell surfaces and non-specific cell tagging by working fast, keeping cells and solutions cold through the use of pre-cooled solutions, and by adhering to the incubation times and temperatures specified in the protocol. Increased temperature and prolonged incubation times may lead to non-specific cell labelling thus lowering cell purity and yield.
  • When processing different numbers of cells observe the following guidelines: keep blocking, antibody cocktail and ferrofluid incubation times and temperatures the same. Add 5 μL of Blocking Reagent-1 per each 1 x 107 cells being processed. Add 10 μL of Antibody Cocktail per each 1 x 107 cells being processed. Add 15 μL of Streptavidin Ferrofluid per each 1 x 107 cells being processed.
  • When processing 2 x 108 cells or fewer use the 12 x 75 mm (5 mL) tubes with the MagCellect Magnet horizontally positioned to accommodate up to six 5 mL tubes. Do not process more than 2 x 108 cells in each 5 mL tube and do not exceed a total reaction volume of 3 mL in each tube. A reaction volume of 2 mL is recommended for processing 1 x 108 cells. A reaction volume of 1 mL is recommended when processing 5 x 107 or fewer cells. Reaction volume adjustments must be made using 1X MagCellect Buffer just prior to the magnetic separation step.
  • When processing greater than 2 x 108 cells use the 17 x 100 mm (15 mL) tubes with the MagCellect magnet positioned vertically to accommodate up to two 15 mL tubes. Do not process more than 6 x 108 cells in each 15 mL tube and do not exceed a total reaction volume of 9 mL in each tube. When using this larger tube, increase the reaction volume before the magnetic separation step according to the following formula: 3 mL for each 2 x 108 cells processed. Also increase the incubation time in the magnet described to 8 minutes. Reaction volume adjustments must be made using 1X MagCellect Buffer just prior to the magnetic separation step.

Citations for MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

10 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors
    Authors: A Vorontsova, TJ Cooper, J Haj-Shomal, M Benguigui, S Levin, B Manobla, R Menachem, M Timaner, Z Raviv, Y Shaked
    Oncogene, 2023-01-16;0(0):.  2023-01-16
  2. Adult stem cell deficits drive Slc29a3 disorders in mice
    Authors: S Nair, AM Strohecker, AK Persaud, B Bissa, S Muruganand, C McElroy, R Pathak, M Williams, R Raj, A Kaddoumi, A Sparreboom, AM Beedle, R Govindaraj
    Nat Commun, 2019-07-03;10(1):2943.  2019-07-03
  3. Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation.
    Authors: Muruganandan S, Govindarajan R, McMullen N, Sinal C
    Stem Cells, 2016-11-11;35(3):711-724.  2016-11-11
  4. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
    Authors: Cermakova K, Tesina P, Demeulemeester J, El Ashkar S, Mereau H, Schwaller J, Rezacova P, Veverka V, De Rijck J
    Cancer Res, 2014-07-31;74(18):5139-51.  2014-07-31
  5. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.
    Authors: Thanasopoulou A, Tzankov A, Schwaller J
    Haematologica, 2014-06-20;99(9):1465-71.  2014-06-20
  6. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.
    Authors: Muruganandan S, Dranse H, Rourke J, McMullen N, Sinal C
    Stem Cells, 2013-10-01;31(10):2172-82.  2013-10-01
  7. Functional role of matrix metalloproteinase-8 in stem/progenitor cell migration and their recruitment into atherosclerotic lesions.
    Authors: Xiao, Qingzhon, Zhang, Feng, Lin, Luyang, Fang, Changcun, Wen, Guanmei, Tsai, Tsung-Ne, Pu, Xiangyua, Sims, David, Zhang, Zhongyi, Yin, Xiaoke, Thomaszewski, Binia, Schmidt, Boris, Mayr, Manuel, Suzuki, Ken, Xu, Qingbo, Ye, Shu
    Circ Res, 2012-10-15;112(1):35-47.  2012-10-15
  8. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
    Authors: Liu T, Jankovic D, Brault L, Ehret S, Baty F, Stavropoulou V, Rossi V, Biondi A, Schwaller J
    Leukemia, 2010-01-14;24(3):601-12.  2010-01-14
  9. Regulation of surfactant protein B gene expression in bone marrow-derived cells.
    Authors: Field-Corbett C, English K, O'Dea S
    Stem Cells, 2009-03-01;27(3):662-9.  2009-03-01
  10. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
    Authors: Tiedt R, Coers J, Ziegler S, Wiestner A, Hao-Shen H, Bornmann C, Schenkel J, Karakhanova S, de Sauvage FJ, Jackson CW, Skoda RC
    Blood, 2008-10-09;113(8):1768-77.  2008-10-09

FAQs

  1. When using MacCellect Cell Isolation kits (MAGM*** or MAGH***), why is it important to lyse red blood cells before starting the cell isolation protocol?

    • It is important to remove red blood cells before the isolation protocol using MagCellect isolation kits because not doing so can cause a poorer yield of selected cells. Red blood cells become sticky during the incubation protocols and may interfere with the interactions needed for removal of unwanted populations.

View all Cell Selection and Detection Kit FAQs
Loading...

Reviews for MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit

There are currently no reviews for this product. Be the first to review MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit and earn rewards!

Have you used MagCellect Mouse Hematopoietic Cell Lineage Depletion Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review